The Future of Generic Drugs and Strategies for Commercial Success

Although the US is currently dominating the generics market, emerging markets have been the most important geographical growth drivers for generics in the recent past. For example, Indian pharmaceutical companies are already well positioned in this industry, with their advanced technological capabilities and low-cost manufacturing.

Despite emerging economies having relatively lower healthcare spending than developed economies, their healthcare costs are expected to significantly rise in the near future, driven by the adoption or expansion of universal healthcare and a growing incidence of lifestyle diseases.

Therapy Areas with Highest Levels of Genericization, 2016–2021

Generic drugs

As seen in the above figure, the oncology (19%) and cardiovascular (18%) therapy areas seem to be the most promising for genericization in the next five years. The metabolic (14%), respiratory (11%), and gastrointestinal (11%) therapy areas follow. Overall, the disease areas with higher prevalence rates and levels of need will see more growth in the generics market as more innovative molecules will be developed for these diseases, whereas in the case of neurology (6%), even though the unmet need is high, the R&D and innovation have been slow compared with the other therapy areas.

CBR Pharma Insight’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. CBR Pharma conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market.

Let’s get started...

Broker Rating Markets Available Fees Open an Account
Kawase Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 3.60 /5
(15 votes cast)
Loading...
Shares, Indices, Forex and Oil Spread From 0.1 and 0.2% Commission Visit Website
MaxFx Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 4.70 /5
(89 votes cast)
Loading...
Indices, Forex, Metals, Shares From 0.1 Raw Interbank Spread Visit Website
London Capital Group (LCG) Logo
1 Star2 Stars3 Stars4 Stars5 Stars
Rating 0.42 /5
(126 votes cast)
Loading...
CFDs - Foex, Indices, Stocks, Commodities, Bonds, Interest Rates Variable spreads from 1.2 and small 0.1 commission on Shares Visit Website
Risk warning: Your capital may be at risk. CFD trading is suitable for experienced traders and not beginners.